From: BTLA biology in cancer: from bench discoveries to clinical potentials
Group[ref] | Cancer | Population | Main Method | BTLA expression | BTLA function | Correlation with OS |
---|---|---|---|---|---|---|
Liao et al. [54] | PTCL | Chinese | RT-qPCR | ↑ mRNA in T-cells; ↑ in patients with advanced disease | - | - |
Carreras et al. [55] | FL | Western FL patients | IHC | Detected in the germinal center of the follicular area as well as in the interfollicular compartment; In some cases, detected also in the mantle and marginal zone area | - | Yes; positive correlation |
Quan et al. [56] | DLBCL | Chinese | FC | ↑ % of BTLA + CD3 + T-cells; ↑ levels in patients with advanced disease | BTLA + CD8 + T-cells produced ↓ perforin and granzyme B; BTLA + CD4+/CD8 + T-cells expressed ↑ levels of pSTAT3 | - |
Karabon et al. [25] | CLL | Polish | FC | ↑ mRNA levels in B and T-cells; ↓ on CLL B-cells | BTLA + CD19 + and CD3 + less responsive to PMA stimulation | - |
CLL | Spanish | FC | ↑ on CLL B-cells, T-cells, NK-cells | BTLA activation led to↓IL-2 and IFNγ production; BTLA blockade resulted in ↑ IFNγ production and NK-cell/ CD8 + T-cell mediated response | Yes; positive correlation | |
Mittal et al. [59] | murine model of LC | - | FC | ↑ on proportion of BTLA + CD8+/CD4 + T-cells | BTLA + CD8 + T-cells produced ↓ IL-2 and TNF | - |
Wang et al. [60] | LC | Chinese | FC | ↑ on pleural fluid T-cells in lung cancer patients | - | - |
Thommen et al. [61] | NSCLC | Swiss | FC | Expressed on CD8 + TILs, but not on PB CD8 + T-cells | BTLA + CD8 + TIL co-expressed high levels of PD-1, TIM-3, CTLA-4, and LAG-3; | - |
Li et al. [62] | NSCLC | Chinese | IHC | Expressed on tumor cells; ↑ in patients with lymph node metastasis and advanced disease | - | Yes; negative correlation |
Shen et al. [63] | LUAD | Chinese | IHC | Expressed on TILs | - | - |
Lou et al. [64] | LUAD | - | RS | ↑ mRNA levels in patients with the present EMT | - | - |
Zhang et al. [65] | LUAD | - | RS | ↑ mRNA levels in low-risk group | - | - |
Derré et al. [26] | melanoma | Swedes | FC | CD8 + T-cells expressed ↑ BTLA levels; Differentiation of CD8 + T-cells into effector cells was associated with ↓ BTLA expression | - | - |
Malissen et al. [66] | melanoma | French | FC, IHC | Expressed on CD4 + and CD8 + TILs in contiguity with HVEM + melanoma cells | - | - |
Radvanyi et al. [67] | melanoma | American | FC | ↑ frequencies of CD8 + BTLA + and CD8 + BTLA + TIM-3 + TILs in responders to ACT | - | - |
Haymaker et al. [68] | melanoma | American | FC | ↑ on CD8 + TILs in patients responding to ACT therapy | ↓ CD8 + BTLA + TILs proliferation and cytokine production; ↑ CD8 + BTLA + TILs survival | - |
Fourcade et al. [69] | melanoma | American | FC | ↑ on tumor-specific NY-ESO-1 CD8 + T-cell | BTLA blockade ↑ IFN-γ, TNF, and IL-2 production and proliferation by tumor-specific NY-ESO-1 CD8 + IFNγ + T-cell | - |
Gestermann et al. [70] | melanoma | - | - | Expressed on CD4 + and CD8 + TILs | BTLA blockade led to ↓ melanoma cell number and ↑ T-cell:melanoma cell ratio | - |
Érsek et al. [71] | melanoma | Hungarians | FC | Under MAF stimulation, BTLA expression ↑ on CD45RO + non-naïve/memory cytotoxic T-cells | - | - |
Dong et al. [72] | melanoma | - | RS | ↑ mRNA and protein levels in patients with metastatic | - | Yes, positive correlation |
Feng et al. [73] | GC | Chinese | IHC | Positive staining in gastric cancer cells | - | Yes, negative correlation |
Lan et al. [74] | GC | Chinese | IHC | Positive staining mainly within the cytoplasm of gastric cancer cells; ↑ levels associated with lymph node metastasis | - | Yes, negative correlation |
Azarafza et al. [75] | GC | Iranian | RT-qPCR IHC | ↑ mRNA and protein expression in advanced stages | - | - |
Song et al. [76] | CRC | - | RS | ↓ mRNA levels in cancer tissue; ↑ levels associated with lymph node metastasis; Associated with the degree of tumor infiltration and expression of B, T, and NK-cells markers | Potential role in the regulation of TCR and BCR signaling pathways and NK-cell-mediated cytotoxicity pathways of TILs | Yes, positive correlation |
Kamal et al. [78] | CRC | Egyptian | RT-qPCR | ↑ mRNA in PBMCs; ↑ in advanced stages; Correlation with CTLA-4, LAG-3, and TIM-3 levels | - | Yes; negative correlation |
Sorrentino et al. [79] | CRC | - | RS | Correlation with FCRL4, SIGLEC6, and SIGLEC2 levels as well as with B and T-cell markers | - | Yes; negative correlation |
Oguro et al. [80] | GBC | Japanese | IHC, IF | Expressed in the proportion of CD3+, CD4+, CD8+, and CD20 + TILs, CD14 + monocytes, CD68 + macrophages, CD1a+, CD207+, and CD208 + DCs | - | Yes; negative correlation |
Zhao et al. [81] | HCC | Chinese | FC | ↑ on CD4 + T-cells; ↑ % of PD-1 + BTLA + CD4 + TILs associated with advanced stages | ↓ capacity for IFNγ production by BTLA + CD4 + T-cells | - |
Liu et al. [82] | HCC | Chinese | FC | ↑ on PB CD4 + T-cells | ↓ capacity to IFNγ production; BTLA blockade ↑ production of IFNγ in PB CD4 + and CD8 + T-cells | - |
Yi et al. [83] | HCC | Chinese | IHC | ↑ on CD8 + effector memory TILs | - | - |
Yu et al. [84] | OSCC | - | RS | Positively correlated with PD-L1 expression; Negatively correlated with the TMB | - | Yes; negative correlation |
Weber at al [85]. | OSCC | German | NS | ↑ in tumor samples | - | - |
Qian et al. [86] | TC | Chinese | FC | ↑ on Tfh | - | - |
Luo et al. [87] | TC | Chinese | IHC | Expressed on TILs | - | No correlation |
Imai et al. [88] | EOC | Japanese | FC | Expressed on 37.6% of CD4 + TILs and 15.7% of CD8 + TILs; Correlation between BTLA levels on CD4+/CD8 + TILs and age, stage, or histological type of EOC | - | - |
Chen et al. [5] | EOC | Taiwan | RT-qPCR | Detected in 59% of patients; BTLA + had ↑ incidences of advanced disease | - | Yes; negative correlation |
Muenst et al. [89] | BC | Swiss | IHC, FC | Detected in 2.3% of cases | - | - |
Fang et al. [90] | BC | - | RS | ↓ mRNA expression | - | - |
Filippi et al. [91] | BC | - | RS | ↓ mRNA expression | - | Yes; negative correlation |
Sekar et al. [92] | murine model of MC | - | FC, RS | Detected on type I NKT-cells | BTLA blockade led to ↓ tumor growth and to ↑ of NK1.1 + T-cells and PBS-57-loaded CD1d tetramer-recognizing type I NKT-cells numbers, and to ↑ production of perforin and granzyme B | No correlation |
Woroniecka et al. [93] | GBM | Polish | FC | ↓ on TILs | - | - |
Shen et al. [94] | HGG | Chinese | FC | ↑ on CD3 + CD4 + and CD3 + CD8-CD4- TILs; ↑ on PBMC | - | - |
Choi et al. [97] | murine model of GBM | - | FC | ↑ on TILs non-Treg CD4 + T-cells over time after tumor implantation | anti-PD-1 and anti-BTLA combination therapy resulted in ↑ IFN-γ expression and secretion by CD4 + and CD8 + TILs | - |